• Explore /
  • Poster
  • / Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis: Results from the ACE-536-MF-001 study.

Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis: Results from the ACE-536-MF-001 study.

Abstract Poster

Authors

Aaron Gerds

Aaron Thomas Gerds

Cleveland Clinic, Cleveland, OH

Aaron Thomas Gerds , Claire Harrison , Jean-Jacques Kiladjian , Ruben A. Mesa , Alessandro M. Vannucchi , Rami S. Komrokji , Prithviraj Bose , Marina Kremyanskaya , Adam J. Mead , Jason R. Gotlib , Fabian Sanabria , Niloufar Marsousi , Ana Carolina Giuseppi , Huijing Jiang , Jeanne M. Palmer , Kelly McCaul , Vincent Ribrag , Srdan Verstovsek , Francesco Passamonti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies

Sub Track

Myeloproliferative Neoplasms (MPN) and Mast Cell Disorders

Clinical Trial Registration Number

NCT03194542

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 7016)

DOI

10.1200/JCO.2023.41.16_suppl.7016

Abstract #

7016

Poster Bd #

146

Abstract Disclosures

Similar Posters

First Author: Ruben A. Mesa

First Author: Yi Zhang

First Author: Haris Ali

First Author: Yi Zhang